Ulsan University Hospital

Ulsan, Ulsan Gwang'Yeogsi 44033

1 studies enrolling now · 2 studies all time

What they study most

HR+/HER2- Breast Cancer, Magnetic Resonance Imaging

Studies at this site

• BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease — Recruiting now
• Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose — Completed